Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/01/2005US6960435 Amyloid β protein agglutination-controlling factor
11/01/2005US6960433 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
11/01/2005US6960431 Inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof and peptide associated with a transporter that is capable of
11/01/2005US6960430 Screening methods for compounds useful in the regulation of cell proliferation
11/01/2005US6960429 Inhibition of viral gene activities
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005CA2391229C Sorghum dwarfing genes and methods of use
11/01/2005CA2303526C Hepatitis c virus cell culture system
11/01/2005CA2294078C C-peptide specific assay procedure
10/2005
10/30/2005CA2507566A1 Carnobacterium divergens m35 and bacteriocin produced therefrom
10/29/2005CA2503336A1 Ns5a nucleoside sequence variation as a marker
10/27/2005WO2005101016A2 Analysis of structure stabilities of diseases-causing proteins and their mutants
10/27/2005WO2005101014A2 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases
10/27/2005WO2005101003A1 Diagnostics and therapeutics for diseases associated with purinoceptor 4 type y (p2y4)
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100986A1 Diagnostics and therapeutics for diseases associated with tachykinin receptor 1(tacr1)
10/27/2005WO2005100984A1 Method of separating and concentrating protein and conditioning sample
10/27/2005WO2005100586A2 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
10/27/2005WO2005100575A2 Rice pollen-specific promoters and uses thereof
10/27/2005WO2005100573A2 Fungal promoters for expressing a gene in a fungal cell
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100566A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005WO2005100565A1 Novel fluorescent protein and gene coding for the same
10/27/2005WO2005100564A2 Intervention in the energy metabolism of eukaryote cells for the purposes of selection and increased expression
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100554A1 Novel infectious bursa fabricii's disease virus and vaccine containing the virus
10/27/2005WO2005100545A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
10/27/2005WO2005100544A2 SMALL RNAs AND BACTERIAL STRAINS INVOLVED IN QUORUM SENSING
10/27/2005WO2005100401A2 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005WO2005100397A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005WO2005100396A1 Diagnostics and therapeutics for diseases associated with retinoid x receptor alpha (rxra)
10/27/2005WO2005100395A2 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE
10/27/2005WO2005100394A2 PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF
10/27/2005WO2005100393A1 Methods and compositions for modulating cardiac contractility
10/27/2005WO2005100392A2 Treatment of neuropathic pain with zinc finger proteins
10/27/2005WO2005100391A1 Diagnosis of inflammatory bowel diseases, more particularly ulcerative colitis
10/27/2005WO2005100390A2 Bob-1 specific t cells and methods to use
10/27/2005WO2005100389A1 Osteoblast growth factor
10/27/2005WO2005100388A1 Production of insulinotropic peptides
10/27/2005WO2005100387A1 Monomeric red fluorescent proteins
10/27/2005WO2005100386A2 Canine cold-and menthol-sensitive receptor 1
10/27/2005WO2005100385A2 Compounds that block the c5a receptor and their use in therapy
10/27/2005WO2005100384A2 Ai-2 compounds and analogs based on salmonella typhimurium lsrb structure
10/27/2005WO2005100383A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection
10/27/2005WO2005100381A2 Processes for preparing eptifibatide and pertinent intermediate compounds
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005099858A1 Methods and compositions for simultaneously isolating hemoglobin from red blood cells and inactivating viruses
10/27/2005WO2005099772A2 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
10/27/2005WO2005099752A2 Antigen delivery vectors and constructs
10/27/2005WO2005099745A2 Gcp-170 fusion proteins and uses thereof
10/27/2005WO2005099743A1 Novel use of a polypeptide comprising fas-1 domain
10/27/2005WO2005099741A1 Remedy for motoneuron diseases
10/27/2005WO2005099449A2 Animal model, cells, and treatment for malignant melanoma
10/27/2005WO2005099441A1 Method of screening agrichemical capable of inducing disease resistance and plant for use in the method
10/27/2005WO2005099361A2 MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
10/27/2005WO2005099337A2 Therapeutic peptides
10/27/2005WO2005080425A3 Leucine rich repeat containing protein
10/27/2005WO2005076000A8 Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
10/27/2005WO2005075508A8 Hyperactive stat molecules and their use in assays employing gene activation
10/27/2005WO2005073371A3 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide
10/27/2005WO2005072045A3 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
10/27/2005WO2005066349A3 Genes encoding proteins with pesticidal activity
10/27/2005WO2005066205A3 Antiviral compositions which inhibit paramyxovirus infection
10/27/2005WO2005065707B1 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
10/27/2005WO2005064001A3 Process for preparing l-amino acids using strains of the enterobacteriaceae family
10/27/2005WO2005063813A3 Process for the production of tumor necrosis factor-binding proteins
10/27/2005WO2005063812A3 Cc-chemokine-binding tick proteins
10/27/2005WO2005060642A3 Rationally designed antibodies
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005056596B1 Improved cytokine design
10/27/2005WO2005055703A3 Method of modifying plant phenotypes with nonsymbiotic hemoglobin
10/27/2005WO2005052000A3 Anti-il-20 antibodies and binding partners and methods of using in inflammation
10/27/2005WO2005048693A3 Plant with improved drought tolerance
10/27/2005WO2005044838A8 Cd4+ epitopes of bone morphogenetic proteins
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005033311A3 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis
10/27/2005WO2005027625A3 Transgenic tieg non-human animals
10/27/2005WO2005012531A3 Antibody cdr polypeptide sequences with restricted diversity
10/27/2005WO2005000870A3 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
10/27/2005WO2004111641A3 Methods for detecting cancer and monitoring cancer progression
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2004081030A8 Peptides selectively lethal to malignant and transformed mammalian cells
10/27/2005WO2004070388A8 Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
10/27/2005WO2004068109A3 Autologous or homologous coagulant produced from anticoagulated whole blood
10/27/2005WO2004011496A3 Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
10/27/2005WO2003076586A3 Nucleic acid-associated proteins
10/27/2005WO2003072595A3 Methods and products based on oligomerization of stress proteins
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241018 Arcelin-5 promoter and uses thereof
10/27/2005US20050241010 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease
10/27/2005US20050241009 Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
10/27/2005US20050240014 Connective tissue growth factor homologs
10/27/2005US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
10/27/2005US20050240010 Nucleic acids encoding antagonists of interleukin-15
10/27/2005US20050240009 T-cell epitopes in staphylococcal enterotoxin b
10/27/2005US20050240008 Novel protein, dna thereof and process for producing the same
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 2916